16 May 2022
CNS Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
Author: admintech | Filed under: Press ReleaseRecent approvals of potentially pivotal Berubicin Study into Switzerland, France, and Spain expected to significantly drive patient enrollment Opportunities for Berubicin to be used in additional oncology indications with significant unmet needs HOUSTON, May 16, 2022 /PRNewswire/ — CNS…